Abnormal prolactin elevation in a schizophrenic patient in treatment with quetiapine and mirtazapine. The role of opioid system.
Orlandi
Valerio
V
Speca
Azzurra
A
Salviati
Massimo
M
Biondi
Massimo
M
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D003987:Dibenzothiazepines / Q000008:administration & dosage*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008803:Mianserin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D000078785:Mirtazapine; D011388:Prolactin / Q000097:blood*; D000069348:Quetiapine Fumarate; D017448:Receptors, Dopamine D2 / Q000187:drug effects* / Q000502:physiology; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D017448:Receptors, Dopamine D2; D008803:Mianserin; D000069348:Quetiapine Fumarate; D011388:Prolactin; D000078785:Mirtazapine